As of 5 November 2013, Ambu’s single-use videoscope – aScope 3 – has received market clearance from the U.S. Food and Drug Administration (FDA) for sale in the US, which means that Ambu will launch aScope 3 in the US at the beginning of 2014. aScope 3 was launched in Europe in May 2013.
Contact and further information
Lars Marcher, CEO
Tel. +45 5136 2490
E-mail: lm@ambu.com
Read more online
On the website www.ambu.com/ascope3 you can read more on aScope 3 and the clinical areas it can be used within.
